At Texas A&M’s emerging biomedical corridor you’ll find one of the only places in the world where you can discover new therapies, perform preclinical evaluations, and manufacture them in one convenient location.

Texas A&M Institute for Genomic Medicine
With the world’s largest knockout mouse ES cell library, the Institute can create customized mouse model R&D programs for customized research.
         

Texas A&M Institute for Preclinical Studies
This state-of-the-art large animal GLP (Good Lab Practices) transitional research facility has surgical laboratories, an advanced imaging center and incubator space to accelerate medical device and drug development.

Texas A&M Health Science Center New Campus and Research Park
The new 200-acre campus will have over 50-acres dedicated for public/private partnerships. Collaborative opportunities with world- class investigators abound, as well as access to large and diverse patient populations through affiliated hospitals

         Phase I Opening 2010

National Center for Therapeutics Manufacturing
The nation’s first GMP (Good Manufacturing Practices) facility to incorporate a “flexible by design” system will allow rapid production of precisely targeted quantities of vaccines and medications.

         Opening 2012

G-Con, LLC and Project GreenVax
Texas-based consortuim announces February 24, 2010 Project GreenVax, a groundbreaking vaccine manufacturing research program, where plants and mobile, modular clean room "pods" could revolutionize biopharmaceutical manufacturing process.
         More information to come.


Corporate solutions specialists in virtually every field have the expertise to make your bio venture a success.  Click here for contact information.